格隆汇2月5日丨翔宇医疗(688626.SH)在互动平台表示，公司基于自主研发和具备行业内较全体系的康 复装备基础，可快速实现"脑机接口技术+自有康复设备"的深度融合，提供脑机接口赋能的整体解决方 案，相关产品已进入600多家三甲医院，持续保持公司在行业内的竞争优势。 但招投标和销售等具有滞 后性，截至2025年末，公司脑机接口相关产品实现营收占比较小。 ...

（编辑 任世碧） 证券日报网讯 2月4日，翔宇医疗在互动平台回答投资者提问时表示，2025年12月，翔宇工业旅游景区 获评国家4A级旅游景区，标志着景区在旅游资源开发、服务品质提升、文化内涵挖掘等方面获得认 可，也为安阳"中国康复设备之都"品牌再添文旅亮色。 ...

Investment Rating - The report maintains an "Outperform" rating for the pharmaceutical and biotechnology industry [1] Core Insights - The medical device bidding market is expected to maintain high prosperity in 2025, driven by policy and demand resonance, with a projected market size of CNY 193.76 billion, representing a year-on-year growth of 24% [3][11] - The upward trend for medical device companies is clear for 2026, with multiple policies expected to support the continuous development of medical innovation [4][29] - The report emphasizes the importance of high-end product localization and innovation in driving growth for leading domestic companies [33][41] Summary by Sections Bidding Review - The medical device bidding market in 2025 is projected to reach CNY 193.76 billion, with a year-on-year increase of 24%, second only to the peak in 2022 [3][11] - Monthly bidding trends show sustained high levels, with procurement amounts from July to December ranging from CNY 134 billion to CNY 285 billion [3][11] - Key segments such as medical imaging equipment and radiation therapy devices are expected to see significant growth, with year-on-year increases of 35.37% and 36.34% respectively [3][16] 2026 Outlook - The report anticipates a clear upward turning point for medical device companies in 2026, supported by policies aimed at promoting medical innovation and equipment updates [4][29] - The implementation of large-scale equipment updates and consumer replacement policies is expected to further stimulate market demand [4][29] - The report highlights the potential for domestic companies to benefit from high-end product upgrades and the commercialization of brain-computer interface technologies [4][50] Investment Recommendations - The report suggests focusing on leading domestic companies that are enhancing their high-end and intelligent medical device offerings, such as Mindray, United Imaging, and KaiLi Medical [4][33] - It also recommends monitoring companies involved in brain-computer interfaces and domestic robotics, which are expected to see significant growth in the coming years [4][50]

Core Insights - Public fund institutions have significantly increased their research activities in January, focusing on AI computing power, high-end medical technology, and new energy as the three core investment themes [1][3][5] Group 1: Research Activity - A total of 156 public fund institutions participated in A-share research in January, covering 486 stocks across 17 industries, with a total of 3,992 research instances [1] - Leading institutions such as Bosera Fund, Huaxia Fund, and Penghua Fund conducted the most research, with Bosera Fund leading at 116 instances [2] - The most researched stocks included Zhongji Xuchuang in the communications sector with 61 instances, followed by Aipeng Medical and Xiangyu Medical in the medical sector with 57 and 47 instances respectively [2] Group 2: Industry Focus - The electronics industry was the most researched, with 603 instances covering 71 stocks, followed by the machinery equipment industry with 591 instances covering 67 stocks [2][3] - Other industries such as medical biology, electric equipment, and basic chemicals also saw significant research activity, each exceeding 276 instances [3] Group 3: Emerging Trends - Brain-computer interfaces have emerged as a key focus within the high-end medical sector, driven by technological breakthroughs and commercial progress [4] - Companies like Aipeng Medical and Meihai Medical are actively engaging in brain-computer interface developments, with Aipeng Medical discussing advancements in brainwave technology [4] - The year 2026 is anticipated to be pivotal for the commercialization of invasive brain-computer interfaces, with several companies already in clinical stages [4]

记者｜庞华玮 编辑｜包芳鸣 2026年伊始，A股市场迎来机构调研热潮。 截至1月26日，已有超过500家上市公司接受机构调研，其中工业机械、电子元件、电气设备、 半导体及汽车零配件等行业成为关注重点。 其中，"硬科技"与"出海"主线尤为突出。 在个股层面，大金重工、翔宇医疗、海天瑞声等14家公司获得超百家机构扎堆调研，其中大金 重工以209家机构调研数量位居第一。 机构调研热潮 新年伊始，机构调研活跃。Wind数据显示，截至1月26日，开年以来共有512家A股上市公司 接受了机构调研，调研总次数达801次。这一数据保持了较高的市场热度。 值得关注的是，个股层面，超百家机构扎堆调研14家A股公司，这些个股涨幅显著。 其中，大金重工以209家机构调研数量领先，这家电气设备公司受到了市场的广泛关注。 此外，医疗行业的翔宇医疗、爱朋医疗、美好医疗和博拓生物等分别获得208家、177家、125 家和117家机构调研；计算机行业的海天瑞声、熵基科技、能科科技和航天宏图，分别获得207 家、132家、107家和101家机构调研；汽车领域的超捷股份，获138家机构调研；工业机械领 域的耐普矿机，获132家机构调研；电子领域的 ...

2026年伊始，A股市场迎来机构调研热潮。 机构调研热潮 新年伊始，机构调研活跃。Wind数据显示，截至1月26日，开年以来共有512家A股上市公司接受了机构调研，调研总次数达801次。这一数据 保持了较高的市场热度。 格上基金研究员托合江指出，2026年以来机构调研总次数为801次，而2025年同期为953次，A股机构调研整体活跃度虽有所回落，但当前调研 活动更集中于高景气赛道，凸显机构布局的结构性特征。 从调研频率看，泰和新材以12次调研位居榜首，冰轮环境以10次紧随其后，汇川技术和天禄科技分别为9次，博盈特焊和太力科技分别为8次。 这些高频被调研公司主要集中在制造业和技术创新领域。 从行业分布来看，机构调研呈现出明显的硬科技与高端制造导向。工业机械行业以55家公司被调研位居第一，成为机构关注的焦点领域。 电子元件行业有35家公司获得调研，紧随其后。此外，电子设备和仪器、电气部件与设备、商品化工、汽车零配件与设备、集成电路等行业分 别有29家、27家、26家、22家和22家公司被调研。 截至1月26日，已有超过500家上市公司接受机构调研，其中工业机械、电子元件、电气设备、半导体及汽车零配件等行业成为关注 ...

Core Insights - The A-share market has seen a surge in institutional research activities at the beginning of 2026, with over 500 listed companies undergoing institutional investigations, particularly in sectors like industrial machinery, electronic components, electrical equipment, semiconductors, and automotive parts [1][3][10] - The main themes of focus are "hard technology" and "going global," with a notable concentration on high-growth sectors [5][11] Institutional Research Activity - As of January 26, 2026, a total of 512 A-share companies have been researched by institutions, with 801 total research instances, indicating a high level of market engagement [3][4] - The frequency of research is led by Taihe New Materials with 12 instances, followed by Ice Wheel Environment with 10, and several others with 9 or 8 instances, primarily in manufacturing and technology innovation [3][4] Industry Focus - The industrial machinery sector has the highest number of researched companies at 55, followed by electronic components with 35, and various other sectors including electrical equipment, automotive parts, and integrated circuits [3][4] - Notable companies receiving significant attention include Dajin Heavy Industry with 209 institutions, Xiangyu Medical with 208, and others in the medical and technology sectors [4][6] Stock Performance - The 14 companies that attracted over 100 institutional research instances have generally seen significant stock price increases, with Dajin Heavy Industry rising by 18.43% and the highest increase being 80.19% for Dike Shares in the photovoltaic equipment sector [4][6] Institutional Preferences - Institutions are focusing on companies with technological breakthroughs, capacity expansion, international strategies, and commercialization progress [5][10] - Different types of institutions show varied preferences, with public funds tracking companies like Huichuan Technology and Taihe New Materials, while insurance asset management focuses on value and dividend-oriented companies [9][10] Future Trends - The trend for institutional research is expected to continue focusing on "hard technology" and globalization, particularly in AI computing power, semiconductors, and high-end manufacturing [11][12] - Institutions are likely to adopt a more refined approach, concentrating on leading companies in specific sectors and assessing their performance and long-term growth potential [12]

Industry Overview - The 2026 Brain-Computer Interface (BCI) Developer Conference will be held on February 3-4, 2026, in Tianjin, focusing on "technology open-source, ecological co-construction, and industrial landing" to promote the commercialization of BCI technology from laboratories to clinical and consumer applications [1] - The BCI industry is accelerating its transition from laboratory research to clinical and consumer applications, with policies supporting its development, including its inclusion in the "14th Five-Year Plan" and the establishment of independent billing items by the National Medical Insurance Administration by 2025 [1] - The global market for medical applications in the BCI sector is projected to reach $40 billion by 2030 and grow to $145 billion by 2040, according to McKinsey [1] Company Developments - Xiangyu Medical has made significant progress in BCI, establishing a comprehensive product matrix and five brain science laboratories, with two EEG machines expected to receive registration certificates by June 2025 [1] - Meihua Medical's cochlear implant business is a key application of BCI and represents one of the most successful technologies in clinical applications, with the company collaborating closely with downstream BCI clients to facilitate efficient commercialization from laboratory development to mass production [2]

2026年伊始，A股市场迎来机构调研热潮。 截至1月26日，已有超过500家上市公司接受机构调研，其中工业机械、电子元件、电气设备、半导体及汽车零配件等行业成为关注重点。 其中，"硬科技"与"出海"主线尤为突出。 在个股层面，大金重工、翔宇医疗、海天瑞声等14家公司获得超百家机构扎堆调研，其中大金重工以209家机构调研数量位居第一。 格上基金研究员托合江指出，2026年以来机构调研总次数为801次，而2025年同期为953次，A股机构调研整体活跃度虽有所回落，但当前调研 活动更集中于高景气赛道，凸显机构布局的结构性特征。 从调研频率看，泰和新材以12次调研位居榜首，冰轮环境以10次紧随其后，汇川技术和天禄科技分别为9次，博盈特焊和太力科技分别为8次。 这些高频被调研公司主要集中在制造业和技术创新领域。 从行业分布来看，机构调研呈现出明显的硬科技与高端制造导向。工业机械行业以55家公司被调研位居第一，成为机构关注的焦点领域。 电子元件行业有35家公司获得调研，紧随其后。此外，电子设备和仪器、电气部件与设备、商品化工、汽车零配件与设备、集成电路等行业分 别有29家、27家、26家、22家和22家公司被调研。 值得 ...

翔宇医疗回复称，"星际穿越"等游戏应用在公司平衡功能训练及评估系统等产品中，在该互动中，儿童 需通过重心移动控制飞船躲避陨石，锻炼儿童动态平衡能力；"双人平衡对战"则通过实时数据比拼，培 养团队协作与竞争意识。平衡功能训练及评估系统将高精度传感技术与游戏化训练模式深度融合，打造 出集评估、训练、反馈于一体的智能康复系统，用科技与创意，把枯燥的平衡训练变成孩子抢着玩的游 戏，激发儿童主动参与意识，提高康复效果。 格隆汇1月27日｜有投资者在互动平台向翔宇医疗提问：可以介绍下公司的官微里提到的"星际穿越"游 戏吗？ ...